KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Biocryst Pharmaceuticals (BCRX) Gross Profit (2016 - 2026)

Biocryst Pharmaceuticals filings provide 15 years of Gross Profit readings, the most recent being -$8.8 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 107.03% to -$8.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $449.9 million, a 2.62% increase, with the full-year FY2025 number at $855.8 million, up 95.18% from a year prior.
  • Gross Profit hit -$8.8 million in Q4 2025 for Biocryst Pharmaceuticals, down from $157.2 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $160.6 million in Q2 2025 to a low of -$8.8 million in Q4 2025.
  • Median Gross Profit over the past 5 years was $79.4 million (2022), compared with a mean of $81.5 million.
  • Biggest five-year swings in Gross Profit: surged 1629.78% in 2021 and later crashed 107.03% in 2025.
  • Biocryst Pharmaceuticals' Gross Profit stood at $46.7 million in 2021, then surged by 65.09% to $77.2 million in 2022, then grew by 19.03% to $91.8 million in 2023, then soared by 36.58% to $125.4 million in 2024, then plummeted by 107.03% to -$8.8 million in 2025.
  • The last three reported values for Gross Profit were -$8.8 million (Q4 2025), $157.2 million (Q3 2025), and $160.6 million (Q2 2025) per Business Quant data.